With Becton Dickinson trading at US$149.52, you might be wondering whether the current price reflects a fair deal or if the ...
Becton Dickinson lowers fiscal 2026 adjusted earnings guidance from $14.75-$15.05 per share to $12.35-$12.65 per share compared to the consensus of $14.72. RBC Capital Markets lowered its price ...
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $200.43/share. When a stock reaches the ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Hosted on MSN
William Blair Downgrades Becton, Dickinson and (BDX)
Fintel reports that on May 1, 2025, William Blair downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from Outperform to Market Perform. Analyst Price Forecast Suggests 33.00% Upside As of ...
Becton, Dickinson retains core medtech operations with solid profitability and robust cash flow generation. Learn why BDX ...
Shares of Becton Dickinson and Company (NYSE:BDX) are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting ...
We just covered the 14 Best Defensive Stocks to Invest In Now and Becton, Dickinson and Company (NYSE:BDX) ranks 8th on this ...
It can still be vexing, though, to figure out which healthcare stocks are likely to serve you best over the coming years. I'd ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results